Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Cellular therapies: from academia to industry

Jürgen Kuball • 30 Aug 2020
EBMT 2020
General CAR-T

Jürgen Kuball, MD, PhD, Utrecht University, Utrecht University, Netherlands, discusses how cellular therapies are translated from academia to industrial partners and the challenges associated with this. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Jürgen Kuball

The role of post-transplant DLI to eradicate MRD in leukemia
0:55
The role of post-transplant DLI to eradicate MRD in leukemia
Jürgen Kuball • 13 Feb 2026
Building alignment in CAR-T data collection using a Delphi survey
1:10
Building alignment in CAR-T data collection using a Delphi survey
Jürgen Kuball • 13 Feb 2026
The launch of the CAR-T Passport for Physicians: an update on the work of the GoCART coalition
1:16
The launch of the CAR-T Passport for Physicians: an update on the work of the GoCART coalition
Jürgen Kuball • 13 Feb 2026
Dual targeting of the cancer metabolome & stress antigens to improve efficacy of engineered T-cells
1:12
Dual targeting of the cancer metabolome & stress antigens to improve efficacy of engineered T-cells
Jürgen Kuball • 17 Feb 2024

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals